Aralez Pharmaceuticals Inc (ARZ) Trading Down 5.4%

Shares of Aralez Pharmaceuticals Inc (TSE:ARZ) traded down 5.4% during mid-day trading on Tuesday . The stock traded as low as C$2.68 and last traded at C$2.78. 20,503 shares were traded during trading, a decline of 68% from the average session volume of 63,640 shares. The stock had previously closed at C$2.94.

The firm’s market capitalization is $189.85 million. The stock’s 50 day moving average is $2.28 and its 200-day moving average is $2.28.

TRADEMARK VIOLATION WARNING: This news story was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.com-unik.info/2017/10/10/aralez-pharmaceuticals-inc-arz-trading-down-5-4.html.

Aralez Pharmaceuticals Company Profile

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

What are top analysts saying about Aralez Pharmaceuticals Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aralez Pharmaceuticals Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit